SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTechs latest Phase 3 breast-cancer results are drawing attention: the drug met its primary endpoint but delivered only a modest benefit versus chemotherapy, with higher lung-inflammation rates. Traders are debating whether this and an earlier cancer-trial setback signal broader pipeline weakness or are outweighed by other oncology programs and an upcoming pipeline update.

Twilio, Inc. engages in the development of communications software, cloud-based platforms, and services. It operates through Twilio Communications and Twilio Segments. The Twilio Communications segment includes the platforms Messaging and Voice. The Twilio Segment involves Segment, Engage, Flex, Email, and others. The company was founded by John Wolthuis, Jeffery G. Lawson, and Evan Cooke in March 2008 and is headquartered in San Francisco, CA.

Twilio Inc - Ordinary Shares Class A

Twilio Inc

Twilios quarterly results beat expectations and lifted its full-year outlook, but a softer next-quarter organic growth forecast signaled deceleration and drove a sharp selloff. Traders are debating whether slowing messaging growth and weaker customer expansion outweigh the strong results, while some see the pullback as a potential bounce opportunity.

Schwab Strategic Trust - Schwab US Dividend Equity ETF

Schwab US Dividend Equity ETF

SCHD is drawing attention as traders discuss a shift from volatile technology and growth stocks toward dividend-paying value and defensive holdings amid market uncertainty. Many point to its recent strength and keep accumulating, while others question its yield and warn that rising Treasury yields or a return to tech could weigh on the fund.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Traders are focused on whether Q3 results will show that oral Wegovy demand and international expansion can offset concerns about Eli Lillys competitive lead in GLP-1 drugs. The community is divided: some see the pill rollout and low valuation as recovery potential, while others remain cautious about Novos execution, management and pipeline; the Hengrui licensing deal also drew debate as a longer-term pipeline move.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvanas Q3 report and disclosure that the SEC closed its investigation without recommending enforcement action drove a sharp rally, with traders also pointing to record sales volumes. The move has fueled short-squeeze and momentum talk, while bears argue that an EPS miss, declining per-car margins and the end of numerical guidance undermine the growth story.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A sharp breakout to a fresh 52-week high has put TGTX in focus, with traders pointing to BRIUMVIs commercial growth and anticipation of earnings and upcoming subcutaneous data. Buyout and short-squeeze theories are circulating, but remain speculation; others see the rally as momentum ahead of those catalysts.

Almonty Industries, Inc. engages in the mining, processing, and shipment of tungsten concentrates. Its projects include Almonty Korea Tungsten, Panasquiera mine, Gentung, Almonty Korea Moly, Los Santos mine, and Valtreixal. The company was founded on September 28, 2009 and is headquartered in Dillon, MT.

Almonty Industries Inc

A sharp selloff and persistent volatility dominate discussion, with traders pointing to broader weakness in miners and uncertainty over Sangdongs production ramp and near-term cash flows. Some remain bullish on tungsten-market fundamentals and the mines first shipment, while others say the investor-day discussion offered little new detail and are concerned about execution.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens run to recent highs has traders focused on its upcoming quarterly results, with options activity drawing attention; some view put buying as protection ahead of the report rather than a bearish bet. Optimism around the companys recent positive IMDELLTRA lung-cancer trial results also supports the pipeline discussion.

Crown Castle, Inc. engages in the business of owning, operating, and leasing shared communications infrastructure. It operates through the following segments: Towers, Fiber, and Other. The Towers segment focuses on providing coverage and capacity for wireless carrier network deployments. The Fiber segment includes communications infrastructure offerings of small cells and fiber solutions. The Other segment is involved in corporate assets such as cash and cash equivalents. The company was founded by Ted B. Miller Jr. and Edward C. Hutcheson Jr. in 1994 and is headquartered in Houston, TX.

Crown Castle Inc

Crown Castle International Corp

Reports that SpaceX is in talks to access at least 80,000 U.S. cell sites, including Crown Castles towers, have focused attention on the prospect of a major new leasing customer. Traders see potential tower revenue upside, while skeptics note that no agreement is signed and question whether SpaceXs wireless plans will translate into meaningful demand.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas earnings beat and raised outlook fueled a sharp rally, with traders betting that AI-agent adoption will lift demand for identity security. The bullish AI-security thesis is being weighed against concerns that the stocks run has stretched its valuation, prompting profit-taking and calls for a pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should iShares Russell 1000 ETF (IWB) Be on Your Investing Radar?

Russell, MSCI And Morningstar Set To Load Up On SpaceX Stock — Analyst Warns ‘True Value’ May Be Hard To Pin 

Equity

Index funds will be forced to buy more SpaceX shares as insiders sell, Morningstar said.

Noteworthy ETF Outflows: IWB, PG, HD, KO

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $296.3 million dollar outflow -- that's a 0.6% decrease week over week...

IWB, WMT, ABBV, MA: ETF Outflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $613.1 million dollar outflow -- that's a 1.3% decrease week over week...

Noteworthy ETF Inflows: IWB, LLY, XOM, V

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $381.4 million dollar inflow -- that's a 0.8% increase week over week in...

IBRX Stock Climbs After-Hours: Retail Traders Bet Russell 1000 Inclusion Could Trigger Massive Index-Fund Buying 

IBRX is already part of the Russell 2000, Russell 2500, and Russell 3000, with its current market cap around $7.67 billion.

Notable ETF Outflow Detected - IWB, LLY, V, CAT

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $683.7 million dollar outflow -- that's a 1.5% decrease week over week...

Bullish Two Hundred Day Moving Average Cross - IWB

In trading on Wednesday, shares of the iShares Russell 1000 ETF (Symbol: IWB) crossed above their 200 day moving average of $363.78, changing hands as high as $371.46 per share. iShares Russell 1000 shares are currently trading up about 2.2% on the day. The chart below shows t...

iShares Trust - iShares Russell 1000 ETF

Neutral Sentiment

<ul class="summary-bullets"><li>Morningstar said SpaceX’s weighting in the Russell 1000, Morningstar US Total Market and MSCI USA indexes is set to at least double at upcoming rebalances.</li><li>More than 900 million additional SpaceX shares became eligible for insider sales on Aug.6.</li><li>Morningstar estimates the larger float could propel SpaceX into the Russell 1000’s top 100 holdings.</li></ul>Shares of SpaceX (SPCX) rose 1% overnight late Wednesday as Morningstar said major indexes are preparing to increase the stock’s weighting, forcing index funds to buy more shares just as insiders gain the ability to sell more than 900 million shares.<a href="https://stocktwits.com/symbol/SPCX">SPCX stock</a> gained 1.2% on Wednesday to close at $139.63 and added another 0.6% after-hours.<h2 class="st-heading-2">SpaceX Index Weight Set To Double</h2>“Something odd is going on,” Morningstar said, noting that SpaceX’s weight in the Russell 1000, Morningstar US Total Market and MSCI USA indexes is set to at least double “no matter if its stock price rises or falls” before upcoming rebalances.These indexes use free-float-adjusted market cap, counting only publicly tradable shares. SpaceX’s limited float explains why its $1.4 trillion valuation at the end of July earned it the same 0.08% Russell 1000 weight as $57 billion Delta Air Lines.More than 900 million additional SpaceX shares became eligible for sale by insiders on Aug. 6, which is equal to 143% of the 639 million shares available for public trading shortly after the company’s IPO. Morningstar estimated that the release could increase SpaceX’s float-adjusted market value by 2.43 times, lifting its Russell 1000 weight to about 0.2% and placing it among the index’s top 100 holdings. Assuming July 31 prices, its weight could hit 0.7% following the Dec.11 rebalance.<h2 class="st-heading-2">Index Funds Forced To Buy SpaceX&nbsp;</h2>“Index funds will be forced to buy more SpaceX stock just as insiders are selling,” Morningstar said, warning that “it may be hard to determine the stock’s true value and trading equilibrium in the short term.”The dynamic is unusual as SpaceX shares fell 31% in July. While falling market values typically reduce index weights, the expansion of SpaceX’s tradable float is expected to outweigh its stock decline. “This flies in the face of market-cap weighting,” the brokerage said.Funds including the iShares Russell 1000 ETF (IWB), Vanguard Total Stock Market ETF (VTI) and Invesco MSCI USA ETF (PBUS) bought SpaceX shortly after its June high and held it through its July lows. The Nasdaq 100, tracked by the Invesco QQQ Trust (QQQ), added SpaceX on July 7. The S&amp;P 500 cannot add SpaceX before June 2027 because of its one-year seasoning requirement, while profitability rules could delay inclusion further. Morningstar expects SpaceX to remain below 1% of major U.S. indexes in the near term.<h2 class="st-heading-2">Wolfe Sees 25% SpaceX Upside</h2>Separately, Wolfe Research called SpaceX’s upcoming Louisiana spaceport and recent White House launch-regulation relief “bullish indicators for one of the biggest external constraints on SpaceX’s ambitions.” The brokerage said that the project “paves the way to alleviate the most obvious external constraint” to Starship’s rapid-reuse ambitions.Wolfe maintained an ‘Outperform’ rating and $175 price target, implying a 25% upside from current levels. The firm identified a successful orbital Starship Flight 14 in early September as the next potential catalyst. SpaceX plans to invest $100 billion in the Louisiana facility, which is expected to become Starship’s primary launch hub and support thousands of launches annually. Musk said it could create “probably 10,000 really exciting jobs.” The facility is key to SpaceX’s plans to expand Starlink, deploy orbital data centers and eventually reach Mars.&nbsp;<h2 class="st-heading-2">How Do Retail Traders Feel About SPCX?</h2>On Stocktwits, retail sentiment for SPCX declined to ‘bearish’ from ‘neutral’ levels a week ago amid a 6% rise in 24-hour message volumes.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/spcx_ss_9cb52fb5e5.png" alt="spcx ss.png" width="644" height="341"><figcaption>SPCX sentiment and message volume as of August 27 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Chark/message/662923012">said</a>, “$SPCX Breakout!!!! Stay with me Bulls! This is just getting warmed up!&nbsp; Going to need more jet fuel!!!!”<stembedurl>https://stocktwits.com/Chark/message/662923012</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/Danz_Trades/message/662956136">said</a>, “$SPCX is getting ready to retest $145-$150 if buyers can hold above $140. Above $150 IPO high then we shall see $160 quickly”<stembedurl>https://stocktwits.com/Danz_Trades/message/662956136</stembedurl>SPCX stock has fallen 13% over the past three months.&nbsp;&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rocketlab-insiders-sell-shares-iridium-deal-ceo-secret-defense-programs/cZY8oDBRJpj">Rocket Lab Insiders Sell $5.5M Worth Of Shares As Iridium Deal Advances — CEO Teases Secret Defense Programs&nbsp;</a>

The logo of SpaceX is displayed on a smartphone screen. (Photo by VCG/VCG via Getty Images)

Russell, MSCI And Morningstar Set To Load Up On SpaceX Stock — Analyst Warns ‘True Value’ May Be Hard To Pin

Delta Air Lines, Inc.

iShares Russell 1000 ETF

Invesco MSCI USA ETF

SpaceX

Vanguard Total Stock Market ETF

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$413.05
Prev Close	$420.52
Open	$416.18
Dividend Yield	N/A
50-Day Moving Average	$419.39
Beta	N/A
Avg. Volume	477,772.91
PE Ratio	N/A

52-Week High	$427.04
52-Week Low	$345.21
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

IWB Fundamentals